This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Xeris Pharmaceuticals, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of Evan Cassavaugh
Introduction
Evan Cassavaugh is a notable inventor based in San Diego, CA. He has made significant contributions to the field of therapeutic compositions, particularly in the development of stable sustained release formulations. His work is aimed at improving treatment options for patients suffering from various physical conditions.
Latest Patents
Evan holds a patent for "Stable sustained release therapeutic compositions in aprotic polar solvents and methods of manufacturing the same." This invention focuses on utilizing aprotic polar solvents and ionization stabilizing agents to create storage stable therapeutic formulations. These formulations are designed to dissolve therapeutic agents, allowing for sustained release into the bloodstream, which is particularly beneficial for patients with hypoglycemia.
Career Highlights
Evan Cassavaugh is currently associated with Xeris Pharmaceuticals, Inc., where he continues to innovate in the field of pharmaceutical formulations. His work has the potential to enhance the efficacy of treatments for various disorders, making a significant impact on patient care.
Collaborations
Evan has collaborated with notable professionals in his field, including Steven J. Prestrelski. These collaborations have contributed to the advancement of his research and the development of innovative therapeutic solutions.
Conclusion
Evan Cassavaugh's contributions to the field of therapeutic compositions exemplify the importance of innovation in medicine. His work not only addresses critical health issues but also paves the way for future advancements in treatment methodologies.